ANAL CANCER

Course overview

ANAL CANCER IS A RARE TUMOR COMPRISING ONLY 2.5% OF ALL DIGESTIVE SYSTEM MALIGNANCIES IN THE UNITED STATES. THE PATHOPHYSIOLOGY OF THE DEVELOPMENT OF ANAL CANCER IS BELIEVED TO BE DIRECTLY LINKED TO A COMPLEX INFLAMMATORY PROCESS SECONDARY TO INFECTIONS SUCH AS HSV TYPES 16 AND 18. THIS ACTIVITY EXPLAINS THE PATHOPHYSIOLOGY, CLASSIFICATION, EVALUATION, AND MANAGEMENT IN PATIENTS WITH ANAL CANCER. IT HIGHLIGHTS THE ROLE OF THE INTERPROFESSIONAL TEAM IN TREATING AND DECREASING LONG TERM MORBIDITY IN PATIENTS WITH ANAL CANCER.